[Clinical application of glucarolactone to bladder tumor. II. Effect of SLA on recurrence of bladder tumor].
D000272:Adipates / Q000627:therapeutic use*; D000328:Adult; D000368:Aged; D002295:Carcinoma, Transitional Cell / Q000517:prevention & control*; D005260:Female; D005966:Glucuronidase / Q000037:antagonists & inhibitors*; D006801:Humans; D007783:Lactones / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000517:prevention & control*; D011379:Prognosis; D001749:Urinary Bladder Neoplasms / Q000517:prevention & control* / Q000601:surgery
D000272:Adipates; D007783:Lactones; D005966:Glucuronidase